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Abstract
 
One mechanism regulating the ability of different subsets of T helper (Th) cells to respond to
cytokines is the differential expression of cytokine receptors. For example, Th2 cells express
both chains of the interferon 
 
g
 
 receptor (IFN-
 
g
 
R), whereas Th1 cells do not express the sec-
ond chain of the IFN-
 
g
 
R (IFN-
 
g
 
R2) and are therefore unresponsive to IFN-
 
g
 
. To determine
whether the regulation of IFN-
 
g
 
R2 expression, and therefore IFN-
 
g
 
 responsiveness, is impor-
tant for the differentiation of naive CD4
 
1
 
 T cells into Th1 cells or for Th1 effector function,
we generated mice in which transgenic (TG) expression of IFN-
 
g
 
R2 is controlled by the CD2
promoter and enhancer. CD4
 
1
 
 T cells from IFN-
 
g
 
R2 TG mice exhibit impaired Th1 polar-
ization potential in vitro. TG mice also display several defects in Th1-dependent immunity in
vivo, including attenuated delayed-type hypersensitivity responses and decreased antigen-spe-
cific IFN-
 
g
 
 production. In addition, TG mice mount impaired Th1 responses against 
 
Leishma-
nia major
 
, as manifested by increased parasitemia and more severe lesions than their wild-type
littermates. Together, these data suggest that the sustained expression of IFN-
 
g
 
R2 inhibits Th1
differentiation and function. Therefore, the acquisition of an IFN-
 
g
 
–unresponsive phenotype
in Th1 cells plays a crucial role in the development and function of these cells.
Key words: T helper type 1 cells • interferon type II • interferon receptors • hypersensitivity, 
delayed • cytokines
 
Introduction
 
CD4
 
1
 
 T cells, or Th cells, are key regulators of a vast array
of immune responses. The regulatory and effector functions
of these cells are mediated, in part, by the cytokines they
produce. Mature, effector Th cells can be subdivided into
two functionally distinct subsets based on their cytokine se-
 
cretion profiles. Th1 cells secrete IFN-
 
g
 
, TNF-
 
b
 
, and IL-2,
mediate immune responses against intracellular pathogens,
and are associated with pathological processes such as organ-
specific autoimmune diseases (1). Conversely, Th2 cells
produce IL-4, IL-5, IL-6, and IL-13, mediate immune re-
sponses against extracellular pathogens, and are associated
with allergic immune responses (1–3). It has been estab-
lished that, after activation through their TCR–CD3 com-
plex, naive precursor Th cells can give rise to either one of
these two distinct mature Th populations. The process of
Th subset phenotype acquisition has been shown to be af-
fected by a host of factors, including strength of stimulus
(antigen dose and level of costimulation), route of immuni-
zation, and by the cytokines present in the immediate mi-
croenvironment of the cells (4–6). Cytokines can either
positively or negatively regulate the development of Th
subsets. IL-12 and IFN-
 
g
 
 are associated with Th1 develop-
ment, whereas IL-4 is a Th2-polarizing stimulus. Moreover,
IL-4 and IL-10 inhibit Th1 development, whereas IFN-
 
g
 
 is
thought to suppress polarization of cells towards the Th2
pathway (7–9). More recent work has focused on under-
standing the mechanism by which these cytokines regulate
Th subset development, as well as the molecular differences
between the Th subsets that result from this process.
During their development, Th1 and Th2 cells acquire
differential responsiveness to several classes of extracellular
 
Address correspondence to Paul B. Rothman, Department of Medicine,
Division of Pulmonary, Allergy and Critical Care, P&S 8-425, Columbia
University, 630 W. 168th St., New York, NY 10032. Phone: 212-305-
6982; Fax: 212-305-1870; E-mail: pbr3@columbia.edu 
978
 
IFN-
 
g
 
 Signaling Alters the Function of Th1 Cells
 
ligands including cytokines (10–12). We and others have
shown that responsiveness to IFN-
 
g
 
 is regulated during Th
cell development (13, 14). Unlike precursor Th and Th2
cells, which express a functional receptor for IFN-
 
g
 
 on
their cell surface, Th1 cells do not express the second chain
of IFN-
 
g
 
R (IFN-
 
g
 
R2; previously termed AF-1 or IFN-
 
g
 
R
 
b
 
), and are therefore unable to respond to IFN-
 
g
 
. Con-
sequently, IFN-
 
g
 
 induces signal transducer and activator of
transcription (Stat)
 
1
 
 1 activation and IFN-
 
g
 
–dependent
gene expression in Th2 cells, but not in Th1 cells, suggest-
ing that the regulation of IFN-
 
g
 
R2 expression participates
in some way in Th cell differentiation or function (13).
However, the role of the regulation of IFN-
 
g
 
 responsive-
ness during mature Th cell phenotype acquisition is un-
known.
To examine the importance of IFN-
 
g
 
R2 regulation dur-
ing Th cell differentiation, we generated transgenic (TG)
mice in which IFN-
 
g
 
R2 cDNA expression is controlled by
the human CD2 promoter and enhancer, resulting in con-
stitutive expression of IFN-
 
g
 
R2 in all T cells (15). Analysis
of IFN-
 
g
 
R2 TG mice reveals that the transgene causes de-
fects in both Th1 differentiation and Th1-dependent im-
munity. Naive TG Th cells fail to develop into Th1 cells
under Th1-polarizing conditions in vitro. Furthermore, in
vivo and ex vivo Th1-dependent immune responses such
as T cell memory, class switching to IgG2a, and resistance
to infection with 
 
Leishmania major
 
 are severely impaired in
TG mice. Our results demonstrate that the loss of IFN-
 
g
 
responsiveness is not only associated with, but is required
for, Th1 phenotype acquisition and for the development of
normal Th1 effector function.
 
Materials and Methods
 
Generation of IFN-
 
g
 
R2 TG Mice.
 
IFN-
 
g
 
R2 cDNA (16) was
subcloned into the human CD2 promoter/enhancer cassette (15)
and was injected into fertilized oocytes (C57BL/6 
 
3
 
 CBA/J) that
were reimplanted into pseudopregnant C57BL/6 
 
3
 
 CBA/J F1
mice (The Jackson Laboratory). Litters were screened for
founders by Southern blot of SacI-digested genomic DNA
probed with IFN-
 
g
 
R2 cDNA. Subsequent litters were screened
by PCR using the following primers: 5
 
9
 
-GCACGTGGT-
TAAGCTCTCG (located in the CD2 promoter) and 5
 
9
 
-
TGTCTCTGTGATGTCCGTACA. The mice used for all ex-
periments were bred into the C57BL/6 genetic background for
at least four generations. All animal experiments conformed to
Columbia University’s Institutional Animal Care and Use Proto-
cols.
 
Ribonuclease Protection Assay.
 
Ribonuclease protection assay
was performed as described previously (17). In brief, a SacI-ClaI
fragment, diagrammed in Fig. 1 A, from the CD2-IFN-
 
g
 
R2
construct was subcloned into the pBluescript II SK
 
1
 
 phagemid
(Stratagene). Radiolabeled antisense mRNA probe was synthe-
sized using an RNA transcription kit (Stratagene). Radiolabled
 
probe (10
 
5
 
 cpm) was hybridized with 30 
 
m
 
g of tissue RNA in
80% deionized formamide at 42
 
8
 
C overnight. Samples were then
digested with RNases A and T1 and run on an 8 M urea-6%
acrylamide gel.
 
Cell Culture.
 
Cells were grown in complete RPMI contain-
ing 10 
 
m
 
g/ml penicillin-streptomycin, 2 mM 
 
l
 
-glutamine, 0.1
mM nonessential amino acids, 0.1 mM 
 
b
 
-mercaptoethanol, 1
mM sodium pyruvate, 10 mM Hepes, and 10% fetal bovine
serum.
 
Cytokines, ELISA, Abs, Antigens, and Adjuvants.
 
KLH, DNP-
KLH, CFA, and IFA were purchased from Calbiochem. Abs
(mAbs) were purchased from BD PharMingen. ELISA was per-
formed according to the BD PharMingen protocol and recom-
mended reagents. Recombinant human IL-2 was provided by the
National Cancer Institute Biological Research Branch (Frederick,
MD). Recombinant murine IFN-
 
g
 
 and IL-12 were purchased
from Genzyme. Recombinant murine IL-4 was a gift of Dr. Sat-
want Nurula of Schering-Plough Corp. (Kenilworth, NJ).
 
CD4
 
1
 
 T Cell Purification.
 
CD4
 
1
 
 T cells were purified by
negative selection as described previously (18). In brief, single-
cell suspensions from lymph nodes or spleens containing no red
blood cells were first incubated with rat anti–mouse mAbs against
B cells (anti-B220/CD45R), monocytes (anti-CD11b), and
CD8
 
1
 
 T cells (anti-CD8a/Ly-2) at 20 
 
m
 
g/ml each, washed, and
then incubated with anti–rat IgG Dynabeads (Dynal). Ab-coated
cells were removed using a magnetic concentrator (Dynal). Naive
Th lymphocytes (CD4
 
1
 
Mel-14
 
hi
 
) were purified by cell sorting
using a FACStar™ flow cytometer (Becton Dickinson).
 
In Vitro Th1 and Th2 Polarization and Proliferation.
 
In vitro
Th cell differentiation has been described previously (18). In
brief, 5 
 
3
 
 10
 
5
 
 naive CD4
 
1
 
 T cells were cultured for 7 d on anti-
CD3–coated plates (10 
 
m
 
g/ml) in complete RPMI in the pres-
ence of IL-2 (20 U/ml). Th2 cultures were supplemented with
IL-4 (10 ng/ml) plus anti–IFN-
 
g
 
 mAb (XMG1.2, 15 
 
m
 
g/ml).
Th1 cultures were supplemented with anti–IL-4 mAb (11B11, 10
 
m
 
g/ml) and with either IFN-
 
g
 
 (10 ng/ml) or IL-12 (10 U/ml).
Cells (5 
 
3
 
 10
 
5
 
 live cells per well) were then restimulated on anti-
CD3–coated plates in RPMI and IL-2. 48 h after restimulation,
culture supernatants were assayed for IFN-
 
g
 
 and IL-4 by ELISA.
Polarized cultures were then pulsed for 6 h with [
 
3
 
H]thymidine
(1 
 
m
 
Ci/well).
 
Cell Division Cycle Profile Analysis Using Carboxyfluorescein Diac-
etate Succinimidyl Ester.
 
CD4
 
1
 
 splenocytes (purified as described
above) were labeled with carboxyfluorescein diacetate succini-
midyl ester (CFSE; Molecular Probes) in a modification of a pre-
viously described technique (19). In brief, cells were washed with
serum-free RPMI. Cells (10
 
7
 
 cells/ml) were then labeled with 10
 
m
 
M CFSE in serum-free RPMI at 37
 
8
 
C for 10 min, and CFSE
was then neutralized with complete RPMI. CFSE-labeled CD4
 
1
 
T cells were cultured on anti-CD3 mAb
 
 
 
plus anti-CD28 mAb–
coated plates and polarized as described above. Initial CFSE label-
ing efficiency and the fluorescein intensities at the end of each
experiment were detected using a FACScan™ flow cytometer
(Becton Dickinson). Histogram overlays and peak distribution
analyses were performed using CELLQuest™ software (Becton
Dickinson). All plots represent live, activated CD4
 
1
 
 cells.
 
Generation and Characterization of KLH-specific Th1 and Th2
Clones.
 
Mouse immunization was performed as described previ-
ously (20). In brief, mice were injected with 100 
 
m
 
l DNP-KLH (1
mg/ml in CFA) in the hind footpad. 7 d later, CD4
 
1
 
 T cells were
purified from inguinal lymph nodes and stimulated with antigen
(KLH, 100 
 
m
 
g/ml) plus irradiated C57BL/6 splenocytes as APCs
(21). KLH-specific Th1 and Th2 clones were generated by limit-
 
1
 
Abbreviations used in this paper: 
 
CFSE, carboxyfluorescein diacetate suc-
cinimidyl ester; DTH, delayed-type hypersensitivity; HKLM, heat-killed
 
Listeria monocytogenes
 
; STAT, signal transducer and activator of transcrip-
tion; TG, transgenic; WT, wild-type. 
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ing dilution T cell cloning (22). Th1 and Th2 clones were defined
based on their production of IFN-
 
g
 
 and IL-4, respectively.
IFN-
 
g
 
R2 expression in Th clones was detected by semiquan-
titative reverse transcription PCR in the presence of [
 
32P]dCTP
using total RNA as a template (23, 24). Endogenous IFN-gR2
was amplified from cDNA using the primer pair 59-GCGTC-
CACCCCGCGGTCCCGG and 59-GTCTCTGTGATGTC-
CGTACA. TG IFN-gR2 was amplified using the primer pair 59-
GCACGTGGTTAAGCTCTCG and 59-TGTCTCTGTGAT-
GTCCGTACA.
7 d after antigenic stimulation, KLH-specific Th clones were
treated with either IL-4 or IFN-g. Whole cell protein extracts
were then prepared and assayed for activated Stat complexes by
electromobility shift assay using a bGAS probe, as described pre-
viously (18).
CD41 T cells were isolated from KLH-immunized mice as
described above. 105 cells/well were cultured with 7 3 105 APCs
and KLH. 48 h after stimulation, culture supernatants were ana-
lyzed for cytokines by ELISA. At 72 h, these cultures were pulsed
with [3H]thymidine as described above.
Responses to Listeria monocytogenes. L. monocytogenes was pro-
vided by D. Hirsh (Columbia University, New York, NY) and
was passaged, cultured, and titered as described previously (25).
Heat-killed L. monocytogenes (HKLM) was prepared as described
previously (25). 4–8-wk-old mice were infected by intraperito-
neal injection with a sublethal dose of L. monocytogenes (2 3 106
CFU). In vivo and in vitro assays were performed 4 wk after in-
fection.
Delayed-type hypersensitivity (DTH) was performed as de-
scribed previously (25). In brief, sensitized mice were injected
with HKLM (107 CFU) in PBS in the left hind footpad. The
contralateral footpad was injected with vehicle control. Footpad
swelling was measured 48 h after injection, and is represented as
the difference between the average of triplicate measurements of
thickness in the HKLM- and in the vehicle-injected footpads.
In vitro assays of Th cell function were performed as follows:
CD41 T cells, purified from the spleens of infected mice, were
stimulated at 3 3 105 cells/well with either anti-CD3 mAbs and
IL-2 (as described above), or with irradiated APCs (7 3 105 cells/
well) and HKLM (107 CFU/well). Culture supernatants were re-
moved 48 h after stimulation and assayed for cytokine content by
ELISA. Proliferation rates of cells in each well were determined
after an 18-h pulse with [3H]thymidine.
Antigen-specific Ab Production. Immunization and antiserum
production were performed using a published protocol (26). In
brief, three to five mice per genotype were injected intraperito-
neally with DNP-KLH (as above). Mice received serial booster
immunizations (as described above except DNP-KLN was emul-
sified in IFA) every 30 d. 10 d after each injection, sera were ob-
tained from immunized mice. KLH-specific Ab (IgG2a and
IgG1) levels in these sera were detected by ELISA, as described
(27).
Cytokine Production from In Vivo–primed CD41 T Cells. Mice
were immunized with DNP-KLH, and CD41 T cells were puri-
fied from local lymph nodes as described elsewhere. 105 CD41 T
cells were stimulated with 7 3 105 APCs and KLH (21). 48 h
later, culture supernatants were harvested and assayed for IL-4
and IFN-g by ELISA.
L. major Infection. TG mice (fifth backcross to C57BL/6) and
controls were infected with 1.5 3 107 stationary phase L. major
promastigotes as described previously (28). In vitro Leishmania-
specific IFN-g production and in vivo parasite loads were deter-
mined as described previously (28).
Results
IFN-gR2 TG Mice. To generate mice in which IFN-
gR2 expression is not regulated during Th cell differentia-
tion, the gene encoding the IFN-gR2 was placed under
the control of the human CD2 promoter and enhancer
(Fig. 1 A). Two different lines of TG mice, TG1 and TG2,
were generated. The IFN-gR2 transgene is specifically ex-
pressed in the thymus and spleen, but not in the liver or
kidney, as shown by ribonuclease protection (Fig. 1 B, and
the riboprobe construct in Fig. 1 A). The expression of the
transgene is higher in the thymus than in the spleen in both
lines of IFN-gR2 TG mice (Fig. 1 B). It is likely that the
multiple TG mRNA species protected in this assay reflects
the existence of more than one transcriptional initiation site
in the CD2 promoter (15).
IFN-gR2 TG mice appear normal and thrive in both
conventional and barrier animal facilities. Gross examina-
tion of organs from TG mice reveals no apparent abnor-
malities. Moreover, flow cytometric analysis of thymocytes
(CD4 versus CD8, and CD3 versus CD25), splenocytes
(CD4 versus CD8 versus B220, and B220 versus IgD ver-
sus IgM), and bone marrow cells (B220 versus IgM) dem-
onstrates that IFN-gR2 TG mice have normal lymphocyte
populations in these organs (data not shown).
Altered IFN-gR2 Expression and Dysregulated IFN-g
Signaling in IFN-gR2 TG Th Clones. KLH-specific Th1
(producing IFN-g but not IL-4) and Th2 (producing IL-4
but not IFN-g) clones from DNP-KLH–immunized wild-
type (WT) and TG mice were generated, and the expression
of IFN-gR2 in these clones was determined. Consistent
with previous reports (13, 14), expression of endogenous
IFN-gR2 was detected in Th2 but not Th1 clones derived
from WT mice (Fig. 1 C). In contrast, both Th1 and Th2
clones generated from the two lines of TG mice express
IFN-gR2 from the endogenous and TG loci (Fig. 1 C).
This suggests that expression of the transgene affects the ex-
pression of the endogenous IFN-gR2 locus.
Because expression of IFN-gR2 is obligatory for the
transduction of the IFN-g signal, the altered pattern of
IFN-gR2 gene expression seen in the TG Th1 clones sug-
gests that these cells may have different IFN-g signaling
properties from WT Th1 cells. As expected, after IFN-g
treatment, activated Stat1 complexes were detected in WT
Th2 but not in WT Th1 clones (Fig. 1 D). However, both
Th1 and Th2 clones derived from TG mice were able to
activate Stat1 in response to IFN-g. Interestingly, Stat1 is
constitutively active in TG Th1 clones (Fig. 1 D). The
presence of Stat1 in the STAT–DNA complexes was con-
firmed by supershift with anti-Stat1 mAb (data not shown).
Activation of STATs in response to IL-4 did not differ be-
tween the Th1 and Th2 clones derived from TG and WT
mice (Fig. 1 D). Detection of activated Stat1 in response to
IFN-g treatment in TG CD41 T cell extracts confirms that
both IFN-gR1 and IFN-gR2 are expressed on the surface
of these cells (29). These data indicate that the IFN-gR2
transgene is expressed in TG Th cells and endows TG Th1
cells with the ability to activate Stat1 in response to IFN-g.980 IFN-g Signaling Alters the Function of Th1 Cells
Defective In Vitro Th1 Polarization in IFN-gR2 TG
Mice. Expression of the IFN-gR2 transgene prevents the
loss of responsiveness to IFN-g in Th1 cells. To examine
whether the transgene affects the acquisition of effector Th
phenotypes, naive T lymphocytes (CD41Mel-14hi) from
TG1, TG2, and WT mice were used to reconstitute Th
differentiation in vitro. Th1-polarized CD41 T cells de-
rived from WT mice produced significantly higher
amounts of IFN-g than Th1-polarized CD41 T cells iso-
lated from either of the two IFN-gR2 TG lines (Fig. 2 A).
Similar results were obtained regardless of whether Th1
polarization was induced by IFN-g or IL-12. In the ab-
sence of polarizing stimuli, TG Th cultures produced lower
amounts of IFN-g but similar amounts of IL-4 as WT cul-
tures (data not shown). Furthermore, the levels of IL-4
produced by the Th2-polarized populations did not differ
significantly among CD41 T cells isolated from WT mice
and the two TG lines (Fig. 2 B). These results indicate that
naive IFN-gR2 TG CD41 cells have a reduced Th1 devel-
opmental potential compared with their WT counterparts.
Moreover, despite their Th1 defect, TG CD41 cells do not
have an enhanced Th2 potential in this cell culture system.
IFN-g Signaling Does Not Affect Th Cell Proliferation. A
potential explanation for the impaired in vitro polarization
seen in TG Th cells may be that the transgene causes an in-
herent proliferative defect in these cells. The retention of
IFN-g responsiveness imparted by the transgene could po-
tentially render TG Th1 cells susceptible to the antiprolifer-
ative effects of autocrine, paracrine, or exogenous IFN-g
(30). To explore this possibility, we assayed the proliferation
rates of in vitro–differentiated cells upon restimulation.
Newly differentiated TG Th1 and Th2 cell lines proliferated
at least as well as their WT counterparts upon restimulation
with anti-CD3 mAbs in the presence of IL-2 (Fig. 2 C).
The experiments above did not examine the proliferative
capacity of these cells early in the process of polarization
towards the Th1 and Th2 phenotypes. It may be that it was
not possible to detect significant differences in proliferation
between polarized WT and TG Th cells because before
restimulation, cell numbers were equalized among wells,
thereby masking potential differences in proliferation rates
under polarizing conditions. To examine this possibility,
we tested whether Th1-polarizing conditions reduce the
mitotic potential of TG Th cells by tracking the division of
individual cells in our in vitro Th differentiation system
(19, 31). Purified CD41 splenocytes from WT and TG
mice were labeled with CFSE. Labeled cells were stimu-
lated on anti-CD3–coated plates under several different po-
larizing conditions. 4 d after stimulation, the distribution of
the CFSE label in each culture was analyzed by flow cy-
tometry. A pattern of discrete generations of activated
Th1-polarized cells results from the sequential halving of
the CFSE label (Fig. 3 A). We detected no appreciable dif-
ferences in peak distribution among Th1-polarized WT,
TG1, and TG2 cultures (Fig. 3 B). Therefore, TG and WT
Th cells undergo an equivalent number of cell division cy-
cles when cultured under Th1-polarizing conditions. Fur-
thermore, WT and TG CD41 T cell cultures had a similar
cell division profile regardless of the polarizing stimulus
(data not shown). These data demonstrate that TG and WT
Th cells proliferate at equivalent rates both during and after
polarization towards Th1 or Th2 phenotypes. The defects
Figure 1. The generation of IFN-gR2
TG mice, transgene expression, and IFN-g
responsiveness. (A) A diagram of the CD2
promoter IFN-gR2-CD2 enhancer con-
struct used to generate IFN-gR2 TG mice.
The template used to synthesize the anti-
sense mRNA probe used in RNase protec-
tion assays is diagrammed above the TG
construct. UTR, untranslated region. (B)
The expression of the endogenous (End.)
and TG alleles of IFN-gR2 in different or-
gans was detected by RNase protection. (C)
IFN-gR2 gene expression in Th1 and Th2
clones was detected by reverse transcription
PCR and visualized by autoradiography. T,
transgenic; E, endogenous. (D) The detec-
tion by electrophoretic mobility shift assays
of activated STAT complexes by Th1 and
Th2 clones in response to treatment with
IL-4 or IFN-g. All experiments were re-
peated three times with similar results.981 Tau et al.
in in vitro Th1 differentiation imparted by the IFN-gR2
transgene do not appear to be caused by altered prolifera-
tion of TG Th cells.
Impaired Th1 Function and Th1 Memory Responses in IFN-
gR2 TG Mice. Naive Th cells overexpressing IFN-gR2
appeared to have a reduced ability to acquire a Th1 pheno-
type in vitro, suggesting that in vivo Th1-mediated immu-
nity in IFN-gR2 TG mice may be impaired as well. To
address this, several Th1-mediated immune responses were
examined. DTH is a local, Th1-dependent inflammatory
response elicited by subcutaneous administration of an anti-
gen to a sensitized animal. DTH responses to L. monocytoge-
nes were examined by administration of HKLM to the
footpads of previously infected WT and TG mice. Listeria-
sensitized WT mice responded to antigenic rechallenge
with a robust swelling of the footpad (Fig. 4 A). In contrast,
sensitized TG mice and naive animals responded poorly to
antigenic rechallenge, suggesting that TG mice fail to de-
velop normal Th1-dependent memory responses.
To determine whether the DTH defect observed in TG
mice resides within the CD41 T cell compartment, anti-
gen-specific memory Th cell responses were examined in
vitro. CD41 T cells purified from the spleens of mice sensi-
tized with L. monocytogenes were tested for their ability to
proliferate and secrete cytokines in response to in vitro an-
tigenic rechallenge. Whereas WT Th cells secreted appre-
ciable amounts of IFN-g and IL-2, TG Th cells secreted
negligible amounts of these Th1 cytokines in response to
stimulation with HKLM presented by WT APCs (Fig. 4, C
and D). No IL-4 was detected in either WT or TG Th cul-
tures (data not shown). However, these TG Th cells prolif-
erated similarly to WT Th cells in response to rechallenge
with listerial antigens (Fig. 4 B). Therefore, it is likely that
TG mice are unable to mount a DTH response to HKLM
because, although antigen-specific TG CD41 T cells de-
velop in response to infection with L. monocytogenes, these
Figure 2. IFN-g signaling disrupts Th1 differentiation in vitro, but
does not affect the proliferation of polarized cells. CD41Mel-14hi T cells
were purified from spleens, stimulated with plate-bound anti-CD3 mAbs,
and polarized in vitro for 7 d with IL-4 and anti–IFN-g mAb (Th2) or
anti–IL-4 and either IFN-g or IL-12 (Th1). (A) IFN-g and (B) IL-4 lev-
els in culture supernatants were determined by ELISA 48 h after restimu-
lation. (C) Proliferation rates of in vitro–differentiated cells were deter-
mined after a 6-h pulse with [3H]thymidine. These experiments were
performed three times yielding similar results.
Figure 3. IFN-g signaling does not affect the mitotic profile of Th1-
polarized cultures. (A) CFSE-labeled, purified CD41 splenocytes from
WT, TG1, and TG2 mice (top, middle, and bottom, respectively) were
cultivated on anti-CD3 plus anti-CD28–coated plates and Th1 polarized
with anti–IL-4 mAbs and IL-12. 4 d after the initiation of the culture, cells
were analyzed by flow cytometry for CFSE fluorescence gating on live
CD41 cells. The sequential dilution of intracellular fluorescein, depicted
as peak progression from right to left, represents progressive cell division.
The CFSE label intensity at the initiation of each culture is represented as
a dashed histogram overlaid at the right of each panel. (B) A chart numer-
ically representing the percentages of cells in each peak of the histograms
in A. Results are representative of three independent experiments.982 IFN-g Signaling Alters the Function of Th1 Cells
cells do not appear to be Th1 and are therefore unable to
orchestrate cellular immune responses.
An alternative explanation for the defective DTH re-
sponse in the TG mice may be that Th1 cells do not de-
velop in these mice because of impaired or altered antigen
presentation. To test this possibility, we first examined the
function of APCs from TG mice. There was no difference
between the ability of WT and TG APCs to elicit cytokine
secretion and proliferative responses from normal Th cells
in this assay (Tau, G.Z., and P.B. Rothman, unpublished
observations). In addition, stimulating TG cells with WT
APCs did not ameliorate the observed dysfunction in Th1
cytokine production by IFN-gR2 TG Th cells (Fig. 4, C
and D). These data support the conclusion that, in IFN-
gR2 TG mice, the defect in Th1-dependent immunity is
intrinsic to the CD41 T cell compartment.
IFN-g Signaling Abrogates In Vivo Th1-dependent Ab Pro-
duction. Protein antigens can induce a mixed Th1/Th2
cellular response when used as immunogens. Th1 and Th2
cytokines induce distinct Ig heavy chain isotype class
switching events in B cells, leading to production of IgG2a
and IgG1, respectively (32). The reduced ability of TG Th
cells to produce IFN-g suggests that IFN-gR2 TG mice
may produce an altered pattern of Ig isotypes in response to
immunization with protein antigen. To address this possi-
bility, WT and TG mice were immunized with KLH, and
the levels of different KLH-specific Ig isotypes were mea-
sured after the primary immunization, the first booster, and
the second booster. As expected, KLH-specific IgG1 and
IgG2a mAbs were undetectable after the primary immuni-
zation and the first booster with KLH in either WT or TG
mice (Fig. 5, C and D). After the second booster, both TG
and WT controls produced significant levels of KLH-spe-
cific IgG1, suggesting that the Th2 component of the anti-
KLH immune response is normal in TG mice (Fig. 5 C).
On the other hand, although WT animals produced signif-
icant amounts of antigen-specific IgG2a, KLH-specific Abs
of this Ig isotype were not detected in TG animals (Fig. 5
D). This observation supports earlier data demonstrating
impaired Th1 immunity but normal Th2 responses in IFN-
gR2 TG mice.
It is probable that the impaired in vivo production of
IgG2a by B cells is secondary to a T cell defect. CD41 cells
isolated from KLH-immunized TG mice failed to produce
IFN-g but proliferated normally in response to stimulation
with this antigen, suggesting that non–IFN-g–secreting
KLH-specific Th cells do develop in TG mice (Fig. 5, A
and B). To examine B cell function, IgM1 B cells were pu-
rified from WT and TG mice and stimulated with LPS and
either IFN-g or IL-4 (33, 34). WT and TG B cells pro-
duced similar levels of IgG2a or IgG1 in vitro (data not
shown). Therefore, there does not appear to be an intrinsic
defect in the ability of TG B cells to undergo Ig heavy
chain class switching. Together, these data demonstrate that
the altered Ab production in the TG mice results from ab-
errant Th1 cell development.
Impaired Th1 Response to L. major Infection in IFN-gR2
TG Mice. A healing response to infection with L. major,
an intracellular protozoan, requires robust Th1 immunity
(35). Since it appears that IFN-gR2 TG mice have im-
paired Th1 responses, it is possible that these mice may be
susceptible to infection with L. major. While monitoring
the course of footpad infection with this pathogen, it was
found that TG mice develop larger, more persistent lesions
than their WT littermates (Fig. 6 A). This correlates with a
10-fold greater parasitemia in TG mice, indicating that
these mice are unable to elaborate normal parasite control
mechanisms (Fig. 6 C). CD41 T cells isolated from infected
Figure 4. IFN-g signaling disrupts Th1-depen-
dent memory responses in vivo. (A) DTH responses
to L. monocytogenes. Naive and sensitized (previously
infected) mice were injected subcutaneously with
HKLM in the hind footpad. Swelling was measured
48 h later and represented as the difference in thick-
ness between the HKLM-injected and control
(contralateral, PBS-injected) footpads. Each bar
represents one to four mice. (B–D) Cytokine secre-
tion and proliferation of Th cells in response to an-
tigenic rechallenge. Splenic CD41 T cells from na-
ive and sensitized mice were stimulated with APCs
in the presence or absence of HKLM. 48 h later,
(C) IFN-g and (D) IL-2 levels in culture superna-
tants were quantified by ELISA. (B) Proliferation
rates of these cultures were determined by measur-
ing their [3H]thymidine incorporation in the pres-
ence of IL-2. All experiments were repeated at least
three times with similar results.983 Tau et al.
WT mice exhibited robust proliferative responses as well as
IFN-g and IL-2 production after stimulation with L. major
antigens (Fig. 6 B, and data not shown). On the other hand,
TG CD41 T cells produced negligible amounts of IFN-g
and IL-2, but proliferated normally in response to the iden-
tical stimulus (Fig. 6 B, and data not shown). These data
suggest that although TG mice are capable of developing
antigen-specific Th cells in response to infection with L.
major, these cells do not have a Th1 phenotype.
Resistance to L. major infection is mouse strain depen-
dent (35). C57BL/6 (the genetic background of the TG
mice) mice mount healing responses, whereas BALB/c
mice succumb to infection with this pathogen. It is be-
lieved that the exquisite sensitivity of BALB/c mice to this
pathogen results from their natural propensity towards Th2
responses, as manifested by greater IL-4 and IgE produc-
tion and lower IFN-g and IL-12 levels relative to those de-
tected in C57BL/6 mice (35, 36). Although IFN-gR2 TG
mice are more susceptible to infection with L. major than
WT mice, they do not develop the progressive, nonhealing
lesions seen in BALB/c mice. Moreover, unlike in BALB/c
mice, infected TG T cells do not produce elevated
amounts of IL-4 in response to L. major antigens, nor are
higher IgE levels detected in the serum of infected TG
mice (data not shown). These observations are consistent
with our previous data, but are uncharacteristic of other
systems in which Th1 responses are impaired (35). This
unique Th subset imbalance, characterized by impaired
Th1 parameters in the absence of increased Th2 parame-
ters, is less severe than that reported for BALB/c mice, but
nevertheless correlates well with the intermediate suscepti-
bility phenotype of TG mice (Fig. 6).
Discussion
Prior studies have demonstrated that cytokine and
chemokine responsiveness is regulated during Th cell dif-
ferentiation. However, the significance of many of these
regulatory processes is not well understood. We sought to
determine the importance of regulating IFN-g responsive-
ness for Th subset development and for effector Th func-
tion by generating mice whose Th cells are unable to regu-
late expression of IFN-gR2. Expression of the IFN-gR2
transgene imparts IFN-g responsiveness to Th1 cells,
which do not normally respond to this cytokine.
IFN-gR2 TG mice are unable to mount efficient Th1-
dependent in vivo immune responses such as DTH and
healing after infection with L. major. In addition, these
mice exhibit diminished ex vivo IFN-g production in re-
sponse to immunization with L. monocytogenes and DNP-
KLH. Decreased IFN-g levels are likely responsible for the
lower amounts of KLH-specific IgG2a that are produced
by the TG mice after immunization. These data were cor-
roborated in experiments recapitulating Th cell differentia-
tion in vitro. Here, naive TG Th cells were found to lack
the potential to become Th1 cells in an in vitro culture sys-
tem that specifically examines the intrinsic polarization po-
tential of Th cells since it is devoid of other cell types. This
suggests that the primary immunological defect seen in the
TG mice resides within the CD41 T cell compartment.
Together, these data indicate that the ectopic expression of
IFN-gR2 profoundly impairs Th1 cell development and
Th1-type immune responses in these mice.
Our data suggest that defects in other, non-T cell com-
partments are not responsible for the Th1 defect observed
in TG mice. B cells function normally in these mice. Also,
Figure 5. KLH-specific responses. (A and B)
IFN-g production and proliferation of in vivo–
primed CD41 T cells. 7 d after in vivo immuniza-
tion with KLH, purified CD41 T cells were stimu-
lated in vitro with APCs in the presence or absence
of KLH. (A) IFN-g content of the culture superna-
tants was determined 48 h after stimulation, and (B)
the proliferation rates of these cultures were deter-
mined 72 h after stimulation after a 6-h pulse with
[3H]thymidine. (C and D) KLH-specific Ig produc-
tion. Mice were serially immunized with KLH. Af-
ter each immunization, sera were analyzed for
KLH-specific (C) IgG1 and (D) IgG2a content by
ELISA. These experiments were repeated twice
with similar results.984 IFN-g Signaling Alters the Function of Th1 Cells
TG macrophages do not express the transgene and normally
upregulate expression of MHC class II molecules in re-
sponse to infection with L. monocytogenes. (Tau, G.Z., and
P.B. Rothman, unpublished observations). There were no
detectable differences between WT and TG mice in their
ability to survive primary listeriosis, indicating that listerial
control mechanisms of the innate immune system are intact
(Tau, G.Z., and P.B. Rothman, unpublished observations).
There are several different mechanisms by which the
IFN-gR2 transgene may affect Th1-dependent immune
responses. One possibility is that the IFN-g responsiveness
of Th1 cells imparted by the transgene makes these cells
susceptible to the antiproliferative and antimetabolic effects
of IFN-g. Several studies have suggested that IFN-g may,
in fact, exert its Th1-promoting effects indirectly, by re-
stricting the outgrowth of Th2 cells or by antagonizing the
Th2 developmental pathway rather than by promoting
Th1 phenotype acquisition (30, 37). As TG Th1 cells
would gain the ability to secrete IFN-g during their differ-
entiation, they would, in effect, inhibit their own prolifera-
tion or development, resulting in an initially normal but ul-
timately abortive commitment to the Th1 pathway. The
observation that, during Th1 polarization, the mitotic pro-
gram of activated TG CD41 cells is no different than that
of their WT counterparts speaks against the proliferative
disadvantage hypothesis. Also, we detected no increased
propensity towards Th2 responses in TG mice, supporting
the abortive commitment hypothesis. Furthermore, IFN-g
appeared to have no antiproliferative effect on TG Th1 cell
clones and on TG Th cells during polarization (Tau, G.Z.,
and P.B. Rothman, unpublished observations). However,
it is possible that in vitro–generated, and in vivo–occurring
TG CD41 IFN-g producers have become selectively re-
fractory to the growth-inhibitory effects of this cytokine
despite the fact that certain IFN-g–dependent signaling
molecules, such as Stat1, are activated in these cells in re-
sponse to IFN-g treatment.
We demonstrated that Stat1 is constitutively active in
TG but not in WT Th1 clones. Consequently, a vast array
of Stat1-regulated genes may be expressed in TG but not in
WT Th1 cells. In support of this, we have shown that the
endogenous IFN-gR2 gene itself is expressed in TG Th1
cells but not in WT Th1 cells (Fig. 1 C). This could poten-
tially affect a host of cellular programs in TG mice, includ-
ing the Th1 differentiation process and Th1 effector func-
tions. Therefore, it is possible that signaling downstream of
IFN-g or the expression of IFN-g–dependent genes creates
intracellular conditions that are incompatible with a Th1
effector phenotype. Consequently, the TG “Th1” cells that
do develop may be unable to mediate Th1 functions other
than IFN-g production and may, in fact, not be true Th1
cells.
It is interesting that Th1 cell defects are observed in both
IFN-gR2–deficient and IFN-gR2–overexpressing mice.
The mechanisms underlying these defects are likely to be
different. It appears that the lack of efficient Th1 cell gen-
eration in IFN-gR2–deficient mice results, at least in part,
from decreased levels of the IL-12R (18). Therefore, IFN-g
signaling may be important for the initiation of Th1 cell
differentiation. In contrast, the data herein demonstrate
that sustained IFN-g signaling is deleterious for Th1 cell
development and suggest that the temporal regulation of
IFN-gR2 expression is essential in Th1 cell differentiation.
Unlike other TG or knockout mouse models examining
Th1 cell development and function, IFN-gR2 TG mice
exhibit intermediate susceptibility to infection with L. ma-
Figure 6. Responses to chronic L. major infection. (A) The course of L.
major infection. Lesion size was determined at 7–10-d intervals by calcu-
lating the average difference in thickness between the infected and unin-
fected footpads of at least five mice per group. (B) L. major–specific IFN-g
production. T cells were isolated from lesion-draining popliteal lymph
nodes and stimulated in vitro with APCs and leishmanial antigens. At
48 h, the IFN-g content of the culture supernatants was determined by
ELISA. (C) Parasite load. The number of parasites in cultures of cell sus-
pensions from popliteal lymph nodes was determined by limiting dilution.985 Tau et al.
jor (38–40). Perhaps the block in Th1 development in TG
mice occurs after commitment to the Th1 pathway,
whereas in other mouse models (in which Th1 function is
more severely compromised) the Th1 pathway is blocked
earlier and naive Th cells are effectively unable to begin
differentiation along the Th1 pathway, and therefore de-
fault to the Th2 pathway. Regardless, the Th1 block
caused by the IFN-gR2 transgene appears to be substantial
enough to give rise to significant alterations in this and
other cell-mediated immune responses. Further analysis of
differential gene expression in Th1 cells expressing IFN-
gR2 may provide insight into the molecular events that
define Th1 cell differentiation, and those events that can
disrupt this developmental process.
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